We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » McNeil Submits Remediation Plan to FDA on Troubled Plant
McNeil Submits Remediation Plan to FDA on Troubled Plant
July 23, 2010
The FDA is reviewing Johnson & Johnson (J&J) subsidiary McNeil Consumer Healthcare’s plan to fix manufacturing quality issues as the company suspends operations at its Fort Washington, Pa., facility.